Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-14 Purchase | 2023-03-16 7:16 pm | Rallybio Corp | RLYB | Lieber Jonathan I See Remarks | 5,000 | $5.21 | $26,050 | 5,000 (Direct) | View |
| 2022-06-07 Purchase | 2022-06-08 3:12 pm | Salarius Pharmaceuticals Inc. | SLRX | Lieber Jonathan I Director | 37,500 | $0.1871 | $7,016 | 37,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-20 Option Award | 2024-02-22 4:21 pm | 2025-02-20 2034-02-19 | Salarius Pharmaceuticals Inc. | SLRX | Lieber Jonathan I Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-16 6:20 pm | N/A 2034-02-15 | Rallybio Corp | RLYB | Lieber Jonathan I Chief Financial Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-01 6:33 pm | N/A 2033-02-01 | Rallybio Corp | RLYB | Lieber Jonathan I See Remarks | 240,000 | $0 | 240,000 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 6:12 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Lieber Jonathan I Director | 1,440 | $0 | 2,940 (Direct) | View |
| 2022-11-30 Disposition | 2022-12-01 09:15 am | N/A 2031-09-20 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Lieber Jonathan I Chief Financial Officer | 356,700 | $0 | 0 (Direct) | View |
| 2022-08-21 Option Award | 2022-08-24 8:04 pm | N/A 2032-08-21 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Lieber Jonathan I Chief Financial Officer | 154,700 | $0 | 154,700 (Direct) | View |
| 2022-01-20 Option Award | 2022-01-21 4:10 pm | 2023-02-19 2032-01-19 | Salarius Pharmaceuticals Inc. | SLRX | Lieber Jonathan I Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-09-20 Option Award | 2021-09-21 9:25 pm | N/A 2031-09-20 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Lieber Jonathan I Chief Financial Officer | 202,000 | $0 | 202,000 (Direct) | View |
| 2020-12-02 Option Award | 2020-12-04 4:59 pm | 2021-12-01 2030-12-01 | Salarius Pharmaceuticals Inc. | SLRX | Lieber Jonathan I Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2020-07-14 Option Award | 2020-07-16 08:33 am | N/A 2030-07-13 | Salarius Pharmaceuticals Inc. | SLRX | Lieber Jonathan I Director | 3,000 | $0 | 3,000 (Direct) | View |